Hu Jingwen,Qin Xiaosong. Hypofibrinogenemia Caused by Hemocoagulase Injection: A Retrospective Study on Clinical Laboratory Findings[J].Chinese Medical Sciences Journal, 2020, 35(2): 151-156.
Sabanis N, Paschou E, Gavriilaki E , et al. Hypofibrinogenemia induced by tigecycline: a potentially life-threatening coagulation disorder. Infect Dis 2015; 47(10):743-6. doi: 10.3109/23744235.2015.1043942.
doi: 10.3109/23744235.2015.1043942
2.
Zhang Q, Zhou S, Zhou J . Tigecycline treatment causes a decrease in fibrinogen levels. Antimicrob Agents Chemother 2015; 59(3):1650-5. doi: 10.1128/AAC.04305-14.
doi: 10.1128/AAC.04305-14
pmid: 25547356
3.
de Moerloose P, Casini A, Neerman-Arbez M . Congenital fibrinogen disorders: an update. Semin Thromb Hemost 2013; 39(6):585-95. doi: 10.1055/s-0033-1349222.
doi: 10.1055/s-0033-1349222
pmid: 23852822
4.
Cai H, Liang M, Yang J , et al. Congenital hypofibrinogenemia in pregnancy: a report of 11 cases. Blood Coagul Fibrinolysis 2018; 29(2):155-9. doi: 10.1097/MBC.0000000000000676.
doi: 10.1097/MBC.0000000000000676
pmid: 29176380
5.
Besser MW, Macdonald SG . Acquired hypofibrinogenemia: current perspectives. J Blood Med 2016; 7:217-25. doi: 10.2147/JBM.S90693.
doi: 10.2147/JBM.S90693
pmid: 27713652
6.
Zhou HB . Hypofibrinogenemia caused by hemocoagulase after colon polyps excision. Am J Case Rep 2017; 18:291-3. doi: 10.12659/AJCR.902059.
doi: 10.12659/ajcr.902059
pmid: 28325889
7.
Qi X, Wang J, Yu X , et al. Hemocoagulase might not control but worsen gastrointestinal bleeding in an elderly patient with type II respiratory failure. Transl Gastroenterol Hepatol 2017; 2(9):71. doi: 10.21037/tgh.2017.08.08.
doi: 10.21037/tgh
8.
Mosesson MW . Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005,3(8):1894-904. doi: 10.1111/j.1538-7836.2005.01365.x.
doi: 10.1111/j.1538-7836.2005.01365.x
pmid: 16102057
9.
Martis N, Chirio D, Queyrel-Moranne V , et al. Tocilizumab-induced hypofibrinogenemia: a report of 7 cases. Joint Bone Spine 2017; 84(3):369-70. doi: 10.1016/j.jbspin.2016.04.008.
doi: 10.1016/j.jbspin.2016.04.008
pmid: 27324602
10.
Wolberg AS . Thrombin generation and fibrin clot structure. Blood Rev 2007; 21(3):131-42. doi: 10.1016/j.blre.2006.11.001.
doi: 10.1016/j.blre.2006.11.001
11.
Wang Z, Li J, Cao L , et al. Hypofibrinogenemia caused by long-term administration of hemocoagulase: three cases report and literature review. Zhonghua Xue Ye Xue Za Zhi 2014; 35(1):50-2. Chinese. doi: 10.3760/cma.j.issn.0253-2727.2014.01.013.
doi: 10.3760/cma.j.issn.0253-2727.2014.01.013
pmid: 24602733
12.
Wu GT, Zhang XH, Shi YL . Haemostasis mechanism of action of hemocoagulase for injection. China Med Herald 2011; 8(11):47-9.
13.
Xu HY, Shu HR. The effect of Hemocoagulase in the functional endoscopic sinus surgery. Chin J Biochem Pharmaceut 2011; 32(1):54-6.Chinese.
14.
Cai XJ, Yan Z, Zhang JX, et al. Application of hemocoagulase in functional endoscopic sinus surgery. J Tongji Uni (Med Sci) 2014;35(1):118-9,123. Chinese. doi: 10.3969/j.issn1008-0392.2014.01.027.
15.
Faraday N . Fibrinogen concentrate and allogeneic blood transfusion in high-risk surgery. Anesthesiology 2013; 118(1):7-9. doi: 10.1097/ALN.0b013e3182715d6c.
doi: 10.1097/ALN.0b013e3182715d6c
pmid: 23249924
16.
Levy JH, Welsby I, Goodnough LT . Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion 2014; 54(5):1389-405. doi: 10.1111/trf.12431.
doi: 10.1111/trf.12431